Psychiatry Investig Search

CLOSE


Psychiatry Investig > Volume 20(4); 2023 > Article
Kim, Kang, Kim, Kim, Choi, Lee, Kim, Kim, Ahn, and Jeong: Ghrelin Modifies the Impact of Life Stress on Suicidality in Patients With Acute Coronary Syndrome

Abstract

Objective

This study investigated associations of life stressors and serum ghrelin levels with suicidal ideation (SI), and evaluated the potential mediating effect of ghrelin on associations between life stressors and SI in patients with acute coronary syndrome (ACS).

Methods

In total, 969 ACS patients recruited from a tertiary university hospital in Korea within 2 weeks of disease onset were evaluated in terms of life stressors (using the List of Threatening Events Questionnaire), serum ghrelin levels, and SI (using the “suicidal thoughts” item of the Montgomery-Asberg Depression Rating Scale). Covariates included sociodemographics, depression, vascular risk factors, and disease severity. After 1 year, 711 patients were re-evaluated in terms of SI; logistic regression was performed with adjustment for covariates.

Results

Life stressors were significantly associated with SI at baseline and follow-up. Serum ghrelin showed no such associations, but high levels thereof mediated associations of life stressors with SI; significant interaction terms were also observed after adjustment for covariates.

Conclusion

By evaluating life stressors and serum ghrelin levels, clinical prediction of SI in the acute and chronic phases of ACS could be improved.

INTRODUCTION

Acute coronary syndrome (ACS), which is one of the leading causes of disability, is associated with various psychiatric sequelae, such as depression and anxiety [1]. Suicidal behaviors are also common among ACS patients, and are associated with poor outcomes [2]. Suicidal ideation (SI) is a prerequisite for suicidal behaviors, including non-fatal and fatal suicidal attempts, but could also be a treatment target [3]. Identifying potential determinants of SI is thus important.
Stressful life events are major contributors to suicidal behaviors [4], although not all stressors are related to suicidal behaviors [5]. A biological component may link stressful life events with suicidal behaviors [6]. Cortisol is a widely studied effector hormone in the hypothalamus-pituitary-adrenal (HPA) axis [7]. Ghrelin, a hormone mainly produced and secreted by the stomach, penetrates the blood-brain barrier and exerts pleiotropic effects in the central nervous system [8]. Ghrelin levels are increased in animal models of depression, which has been interpreted as a stress response [9] exerted through the modulation of HPA axis activity [8]. In human studies, ghrelin levels were higher in suicide attempters than healthy controls [10,11]. However, in ACS patients, who are vulnerable to suicidal behaviors, the roles of stressful life events and ghrelin in suicidal behaviors are not well understood.
Based on existing evidence of associations of ghrelin with stress and suicidal behaviors, we hypothesized that ghrelin modulates relationships between life stressors and suicidal behaviors in ACS patients as with previous studies investigating mediating effects [12,13]. Using data from a prospective Korean cohort study, we investigated associations of life stressors with acute-phase serum ghrelin levels in ACS patients with SI, in both the acute and chronic phases, and then evaluated potential modulatory effects of serum ghrelin on associations between life stressors and SI.

METHODS

Study design and participants

Our analysis forms part a larger naturalistic, prospective study investigating the psychological sequelae of ACS [14]. Recently diagnosed ACS (ST-segment elevation myocardial infarction (MI), non-ST-segment elevation MI and unstable angina) patients seen in the Department of Cardiology of Chonnam National University Hospital, Gwangju, South Korea were recruited to the parent study in the period 2006-2012 (Supplementary Material in the online-only Data Supplement). Assessments were made within 2 weeks of hospitalization (baseline), and at 1 year thereafter (outpatient follow-up), to investigate the sequalae of ACS in both the acute and chronic phases. Life stressors and serum ghrelin levels were analyzed at baseline, while SI was evaluated in both phases. The study was approved by the Institutional Review Board of Chonnam National University Hospital. All participants provided informed consent (IRB No. 06-026).

Life stressors

Using the List of Threatening Events Questionnaire [15], nine life stressors were evaluated during the 3-month period preceding ACS diagnosis: serious illness of self, serious illness of a close relative, bereavement of a close family member, bereavement of another relative or close friend, marital separation, end of a relationship, problem or disagreement with a close friend or relative, severe economic problems, and theft or loss. The scores for each stressor were summed. Due to the skewed distribution of the data, two life stressor categories were used (absent and present).

Serum ghrelin

Participants were instructed to fast overnight before blood sampling, and to sit quietly for 25-45 min before the blood samples were drawn. Serum ghrelin levels were measured at the Global Clinical Central Lab (Yongin, Korea) using a ghrelin radioimmunoassay kit (EMD Millipore, Billerica, MA, USA). As no clear cutoffs for abnormal serum ghrelin levels have been established, the participants were divided into higher and lower ghrelin groups (median split).

Suicidal ideation

The presence of SI was identified using the “suicidal thoughts” item of the Montgomery-Asberg Depression Rating Scale (MADRS-ST) [16], which was administered by two research nurses blinding to the Mini International Neuropsychiatric Interview (MINI) results and trained and supervised by the project psychiatrist. The MADRS has been standardized in Korean [17]. This item assesses the extent to which life is perceived as not worth living, and the existence of plans for suicide; scores range between 0 (satisfied with life) and 6 (explicit plans for suicide). In this study, SI was considered present when the score on this item was ≥2 (and where a score of 2 corresponds to fleeting suicidal thoughts), as in previous studies [18,19].

Baseline covariates

The following sociodemographic data were collected: age, sex, duration of education, living status (living alone or cohabiting), housing status (owned or rented), and current occupation (employed or unemployed). We also obtained data on personal and family history of depression, as well as current clinical depression. The current clinical depression were determined by a psychiatrist, applying these criteria using the MINI [20], a structured diagnostic psychiatric interview for Diagnostic and Statistical Manual of Mental Disorders, 4th edition [21]. Vascular risk factors of interest included personal and family history of ACS or stroke, diagnosis of hypertension or diabetes mellitus, hypercholesterolemia (fasting serum total cholesterol level >200 mg/dL), obesity (body mass index >25 kg/m2), and current smoking status. Finally, to determine the severity of ACS, we obtained the Killip classification [22], left ventricular ejection fraction (based on echocardiography), and serum levels of the cardiac biomarkers troponin I and creatine kinase-MB.

Statistical analysis

Potential covariates were analyzed according to the presence of SI, at baseline and follow-up, using t-tests and χ2 tests (as appropriate). Variables significantly associated with SI (p< 0.05), and those considered potentially to have an effect on suicidal behaviors [3,23], were included in subsequent adjusted analyses; collinearity was also considered. Correlations between life stressors and serum ghrelin levels were estimated by Spearman’s rho. The associations of life stressors (absent vs. present) and serum ghrelin (higher vs. lower) with SI, at both baseline and follow-up, were analyzed using logistic regression models before and after adjusting for covariates. Mediating effects of serum ghrelin on associations between life stressors and SI were tested for using multinomial logistic regression (adjusted model). All statistical tests were two-sided and p<0.05 was considered significant. The analyses were performed using SPSS software (ver. 27.0; IBM Corp., Armonk, NY, USA).

RESULTS

Recruitment and descriptive data

The recruitment process and prevalence of SI, at both baseline and follow-up, are summarized in Figure 1. In total, 969 ACS patients who met the eligibility criteria and agreed to provide a blood sample were included in the baseline sample. Of these patients, 711 (73%) were re-evaluated at the 1-year follow-up.
SI was present in 195 (20%) and 87 (12%) ACS patients at baseline and follow-up, respectively; the baseline characteristics of these two groups are summarized in Supplementary Table 1 (in the online-only Data Supplement). SI at baseline was significantly associated with female sex, lower education level, rented housing, current unemployment, previous and current depression, and higher troponin I levels. SI at followup was significantly associated with female sex, current unemployment, family history of depression and ACS, current depression, and diabetes mellitus. Based on the findings of this and previous studies [3,23], and on the collinearity seen among our variables, the following nine covariates were selected for subsequent adjusted analyses: sex, education, housing status, employment status, previous and family history of depression, clinical depression status, family history of ACS, and serum troponin I level.

Associations of life stressors and serum ghrelin levels with SI

Serum ghrelin levels were positively correlated with life stressors (Spearman’s ρ=0.072, p=0.045). Associations of life stressors and serum ghrelin levels with SI are described in Table 1. The presence of life stressors was significantly associated with SI, at both baseline and follow-up, before and after adjustment for covariates; however, serum ghrelin levels showed no such associations. The mediating effect of serum ghrelin on associations between life stressors and SI is shown in Figure 2. Associations between life stressors and SI were significant in the higher but not in the lower serum ghrelin group; significant interaction effects were also seen after adjustment.

DISCUSSION

In this longitudinal study of ACS patients, life stressors were significantly associated with SI at baseline and follow-up. Although not associated with SI, high (but not low) serum ghrelin mediated associations of life stressors with SI; significant interaction effects were also seen after adjustment for covariates.
Life stressors are associated with suicidal behaviors in various populations, including depressive patients [4]; our findings confirmed the well-known association between these factors in both the acute and chronic phases of ACS. Previous studies reported higher serum ghrelin levels in suicide attempters than controls [10,11], but we found no such association; differences in study populations (general population vs. ACS patients) and definitions of suicidality (suicide attempt vs. SI) might account for this discrepancy.
We found that serum ghrelin levels mediated the relationships of life stressors with SI. It can be explained that there may be the relationship between the association between serum ghrelin levels and life stressors as well as between serum ghrelin levels and SI. In this study, serum ghrelin levels were significantly and positively correlated with life stressors in line with the known previous associations of ghrelin with stress response [8,9]. Moreover, given that higher serum ghrelin levels are associated with suicide attempts [10,11], it is intuitive that life stressors accompanied by high ghrelin levels may exacerbate suicidality; individuals with lower serum ghrelin levels might be less impacted by life stressors.
Regarding the limitations of this study, no data on suicide attempts or completion were obtained. However, most clinical studies of ACS also used SI as the main outcome measure, because suicidal behavior is relatively rare [19,23,24]. Also, SI was identified using a single item of the MADRS rather than using a specific psychometric instrument measuring SI. Though this method was used in previous studies [18,19], this limitation should be considered to interpret our findings. Furthermore, patients were enrolled from a single hospital, which may limit the generalizability of our findings. However, in terms of reliability (i.e., consistency among evaluations), this could also be a strength of the study. Finally, total ghrelin (rather than des-acyl ghrelin, i.e., the biologically active form that binds to the GHSR-1a) was measured, which may not fully reflect the biological activity of ghrelin. Regarding the strengths of our study, all eligible patients with recently diagnosed ACS were recruited consecutively, which increased the homogeneity of the sample. Furthermore, the patients were evaluated at similar time points (within 2 weeks of diagnosis and 1 year thereafter). Finally, we believe that this is the first study to report a mediating role of serum ghrelin in associations between life stressors and suicidality.
In conclusion, our findings provide insight into the pathogenic effects of stressors on suicidality, suggesting a mediating role of ghrelin. Regarding the clinical implications, predictions of suicidality could be improved by evaluating life stressors and serum ghrelin levels in the acute phase of ACS. It is particularly important for cardiovascular clinics to carry out such evaluations, since evaluating suicidality is challenging for untrained clinicians. Our study represents an important first step toward fully elucidating the mediating role of ghrelin in associations between life stressors and suicidality. Multicenter studies in other settings are needed to validate our findings.

Supplementary Materials

The online-only Data Supplement is available with this article at https://doi.org/10.30773/pi.2022.0372.
Supplementary Material
Eligibility criteria for patients with acute coronary syndrome (ACS)
pi-2022-0372-Supplementary-1.pdf
Supplementary Table 1.
Baseline characteristics by suicidal ideation (SI) status in patients with acute coronary syndrome (ACS)
pi-2022-0372-Supplementary-Table-1.pdf

Notes

Availability of Data and Material

The data that support the findings of study are available from the corresponding author (JM Kim) upon reasonable request.

Conflicts of Interest

Jae-Min Kim declares research support in the last 5 years from Janssen and Lundbeck. Sung-Wan Kim declares research support in the last 5 years from Janssen, Boehringer Ingelheim, Allergan and Otsuka. Jae-Min Kim, a contributing editor of the Psychiatry Investigation, was not involved in the editorial evaluation or decision to publish this article. All remaining authors have declared no conflicts of interest.

Author Contributions

Conceptualization: Jae-Min Kim. Data curation: Jae-Min Kim. Formal analysis: Jae-Min Kim, Hee-Ju Kang. Funding acquisition: Jae-Min Kim. Investigation: Jae-Min Kim, Sung-Wan Kim. Methodology: Jae-Min Kim, Hee-Ju Kang, Ju-Wan Kim, Wonsuk Choi. Project administration: Jae-Min Kim, Youngkeun Ahn, Myung Ho Jeong. Resources: Jae-Min Kim. Software: Jae-Min Kim. Supervision: all authors. Validation: Jae-Min Kim, Hee-Ju Kang, Ju-Wan Kim. Visualization: Jae-Min Kim, Ye Jin Kim. Writing— original draft: Jae-Min Kim, Hee-Ju Kang. Writing—review & editing: all authors.

Funding Statement

The study was funded by a grant of National Research Foundation of Korea Grant [NRF-2020M3E5D9080733] and [NRF-2020R1A2C2003472].

Figure 1.
Recruitment process and prevalence of suicidal ideation (SI) among patients with acute coronary syndrome (ACS).
pi-2022-0372f1.jpg
Figure 2.
Interaction effect of serum ghrelin and life stress on suicidal ideation in patients with acute coronary syndrome. A: Suicidal ideation at baseline. B: Suicidal ideation at follow-up. Data are odds ratios (95% confidence intervals) adjusted for sex, education level, housing status, employment status, previous and family history of depression, current clinical depression, family history of ACS, and the serum troponin I level. *p<0.05; **p<0.01; ***p<0.001.
pi-2022-0372f2.jpg
Table 1.
Associations of serum ghrelin and life stress levels with suicidal ideation (SI) in patients with acute coronary syndrome (ACS)
Exposure Group SI at baseline
SI at follow-up
Total SI presence OR (95% CI)
Total SI presence OR (95% CI)
Unadjusted Adjusted Unadjusted Adjusted
Life stress Absent 545 87 (16.0) 1.00 1.00 409 29 (7.1) 1.00 1.00
Present 485 108 (25.5) 1.80 (1.31-2.47)*** 1.35 (0.95-1.93)** 302 58 (19.2) 3.12 (1.94-5.00)*** 2.72 (1.68-4.43)***
Ghrelin (pg/mL) Higher (≥420) 484 89 (18.4) 1.00 1.00 356 46 (12.9) 1.00 1.00
Lower (<419) 485 106 (21.9) 1.24 (0.91-1.70) 1.15 (0.81-1.64) 355 41 (11.5) 0.88 (0.56-1.38) 0.82 (0.52-1.31)

Values are presented as number or number (%). Adjusted odd ratios (ORs) (95% confidence intervals [CIs]) were estimated adjustment for sex, education, housing, current employment, previous and family history of depression, present clinical depression, family history of ACS, and serum troponin I levels.

* p<0.05;

** p<0.01;

*** p<0.001

REFERENCES

1. Parker G, Bassett D, Boyce P, Lyndon B, Mulder R, Porter R, et al. Acute coronary syndrome-associated depression: getting to the heart of the data. J Affect Disord 2020;269:70-77.
crossref pmid
2. Kim JM, Stewart R, Lee HJ, Kang HJ, Bae KY, Kim SW, et al. Impact of suicidal ideation on long-term cardiac outcomes in patients with acute coronary syndrome: sex-specific differences. Psychother Psychosom 2018;87:311-312.
crossref pmid pdf
3. Kim JM, Kang HJ, Bae KY, Kim SW, Shin IS, Hong YJ, et al. Determinants and escitalopram treatment effects on suicidal ideation in patients with acute coronary syndrome: findings from the K-DEPACS and Es-DEPACS studies. Int J Cardiol 2016;219:225-230.
pmid
4. Pitman A, Osborn D, King M, Erlangsen A. Effects of suicide bereavement on mental health and suicide risk. Lancet Psychiatry 2014;1:86-94.
crossref pmid
5. Feskanich D, Hastrup JL, Marshall JR, Colditz GA, Stampfer MJ, Willett WC, et al. Stress and suicide in the nurses’ health study. J Epidemiol Community Health 2002;56:95-98.
crossref pmid pmc
6. Mann JJ. Neurobiology of suicidal behaviour. Nat Rev Neurosci 2003;4:819-828.
crossref pmid pdf
7. Nandam LS, Brazel M, Zhou M, Jhaveri DJ. Cortisol and major depressive disorder—translating findings from humans to animal models and back. Front Psychiatry 2019;10:974
crossref pmid
8. Spencer SJ, Emmerzaal TL, Kozicz T, Andrews ZB. Ghrelin’s role in the hypothalamic-pituitary-adrenal axis stress response: implications for mood disorders. Biol Psychiatry 2015;78:19-27.
crossref pmid
9. Lutter M, Sakata I, Osborne-Lawrence S, Rovinsky SA, Anderson JG, Jung S, et al. The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress. Nat Neurosci 2008;11:752-753.
crossref pmid pmc pdf
10. Atescelik M, Yilmaz M, Korkmaz S, Goktekin MC, Gurger M, Ilhan N. The relationship between ghrelin and copeptin levels, and anxiety and depression levels in suicide attempts. Clin Psychopharmacol Neurosci 2017;15:256-260.
crossref pmid pmc
11. Kurt E, Güler Ö, Ozbulut O, Altınbaş K, Işingör M, Serteser M, et al. Evaluation of serum ghrelin and leptin levels in suicide attempters. J Psychophysiol 2008;22:76-80.
crossref
12. Choi W, Kim JW, Kang HJ, Kim HK, Kang HC, Lee JY, et al. Interactive effects of serum leptin levels and physical comorbidity on the pharmacotherapeutic response of depressive disorders. Clin Psychopharmacol Neurosci 2022;20:662-674.
crossref pmid pmc
13. Choi W, Kang HJ, Kim JW, Kim HK, Kang HC, Lee JY, et al. Associations of serum serotonin levels with 12-week and 12-month remission in patients with depressive disorders. Clin Psychopharmacol Neurosci 2022;20:248-258.
crossref pmid pmc
14. Kim JM, Bae KY, Kang HJ, Kim SW, Shin IS, Hong YJ, et al. Design and methodology for the Korean observational and escitalopram treatment studies of depression in acute coronary syndrome: K-DEPACS and Es-DEPACS. Psychiatry Investig 2014;11:89-94.
crossref pmid pmc
15. Brugha T, Bebbington P, Tennant C, Hurry J. The list of threatening experiences: a subset of 12 life event categories with considerable longterm contextual threat. Psychol Med 1985;15:189-194.
crossref pmid
16. Montgomery SA, Åsberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-389.
crossref pmid
17. Ahn YM, Lee KY, Yi JS, Kang MH, Kim DH, Kim JL, et al. A validation study of the Korean -version of the Montgomery-Asberg depression rating scale. J Korean Neuropsychiatr Assoc 2005;44:466-476.

18. Murrough JW, Soleimani L, DeWilde KE, Collins KA, Lapidus KA, Iacoviello BM, et al. Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial. Psychol Med 2015;45:3571-3580.
crossref pmid
19. Santos CO, Caeiro L, Ferro JM, Figueira ML. A study of suicidal thoughts in acute stroke patients. J Stroke Cerebrovasc Dis 2012;21:749-754.
crossref pmid
20. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59 Suppl 20:22-33.
pmid
21. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association; 1994.

22. Killip T 3rd, Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol 1967;20:457-464.
pmid
23. Nascimento ER, Maia AC, Soares-Filho G, Nardi AE, Cardoso A. Predictors of suicidal ideation in coronary artery disease. Compr Psychiatry 2015;57:16-20.
crossref pmid
24. Kishi Y, Robinson RG, Kosier JT. Suicidal ideation among patients with acute life-threatening physical illness: patients with stroke, traumatic brain injury, myocardial infarction, and spinal cord injury. Psychosomatics 2001;42:382-390.
crossref pmid


ABOUT
AUTHOR INFORMATION
ARTICLE CATEGORY

Browse all articles >

BROWSE ARTICLES
Editorial Office
#522, 27, Seochojungang-ro 24-gil, Seocho-gu, Seoul 06601, Korea
Tel: +82-2-717-0892    E-mail: psychiatryinvest@gmail.com                

Copyright © 2024 by Korean Neuropsychiatric Association.

Developed in M2PI

Close layer
prev next